Gene · 79188
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-wave Inversions in Precordial Leads: A Case Study of Arrhythmogenic Right Ventricular Cardiomyopathy in a Patient With Recurrent Syncope. | Cureus | 2023 | 37692678 | PubTator, text mining | PubMed |
| Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer. | Aging (Albany NY) | 2023 | 37683130 | PubTator, text mining | PubMed |
| Recapitulation of patient-specific 3D chromatin conformation using machine learning. | Cell Rep Methods | 2023 | 37673071 | PubTator, text mining | PubMed |
| Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells. | BMC Cancer | 2023 | 37670250 | PubTator, text mining | PubMed |
| Clinical and Genetic Features of Korean Inherited Arrhythmia Probands. | Korean Circ J | 2023 | 37653714 | PubTator, text mining | PubMed |
| Multielement Z-tag imaging by X-ray fluorescence microscopy for next-generation multiplex imaging. | Nat Methods | 2023 | 37653120 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure. | Eur Heart J | 2023 | 37639473 | PubTator, text mining | PubMed |
| Clinical implications and immune implications features of TARS1 in breast cancer. | Front Oncol | 2023 | 37637061 | PubTator, text mining | PubMed |
| Methylation Profile of Small Breast Cancer Tumors Evaluated by Modified MS-HRM. | Int J Mol Sci | 2023 | 37628841 | PubTator, text mining | PubMed |
Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. | Cancers (Basel) | 2023 | 37627137 | PubTator, text mining | PubMed |
| From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies. | Europace | 2023 | 37622577 | PubTator, text mining | PubMed |
| An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies. | JCI Insight | 2023 | 37606047 | PubTator, text mining | PubMed |
| Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer. | Aging (Albany NY) | 2023 | 37602872 | PubTator, text mining | PubMed |
| GTM-decon: guided-topic modeling of single-cell transcriptomes enables sub-cell-type and disease-subtype deconvolution of bulk transcriptomes. | Genome Biol | 2023 | 37596691 | PubTator, text mining | PubMed |
| Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation. | Int J Oncol | 2023 | 37594134 | PubTator, text mining | PubMed |
| Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer. | J Inflamm Res | 2023 | 37593196 | PubTator, text mining | PubMed |
| Cytosolic DNA sensing protein pathway is activated in human hearts with dilated cardiomyopathy. | J Cardiovasc Aging | 2023 | 37577061 | PubTator, text mining | PubMed |
| Novel Mutation Glu98Lys in Cardiac Tropomyosin Alters Its Structure and Impairs Myocardial Relaxation. | Int J Mol Sci | 2023 | 37569730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79188/papers?page=8